Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease

[1]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[2]  C. Andersson.  Predictors of cognitive decline in memory clinic patients , 2007 .

[3]  L. Wahlund,et al.  Diagnostic use of cerebral and extracerebral oxysterols , 2004, Clinical chemistry and laboratory medicine.

[4]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[5]  Richard Mayeux,et al.  Relation of plasma lipids to Alzheimer disease and vascular dementia. , 2004, Archives of neurology.

[6]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[7]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[8]  V. Haroutunian,et al.  Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.

[9]  M. M. Mielke,et al.  High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.

[10]  B. Winblad,et al.  Serum lipids and hippocampal volume: The link to Alzheimer's disease? , 2004, Annals of neurology.

[11]  Qian-Li Xue,et al.  Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. , 2007, Archives of neurology.

[12]  V. Leoni.  On the possible use of oxysterols for the diagnosis and evaluation of patients with neurological and neurodegenerative diseases , 2005 .

[13]  H. Steinbusch,et al.  Serum cholesterol, precursors and metabolites and cognitive performance in an aging population , 2003, Neurobiology of Aging.

[14]  H. Soininen,et al.  Serum cholesterol changes after midlife and late-life cognition , 2007, Neurology.

[15]  V. J. Rayward-Smith,et al.  Fuzzy Cluster Analysis: Methods for Classification, Data Analysis and Image Recognition , 1999 .

[16]  K. Rockwood,et al.  Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.

[17]  E T Bullmore,et al.  A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. , 1999, Magnetic resonance imaging.

[18]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[20]  I. Björkhem,et al.  Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain , 2006, Journal of internal medicine.

[21]  M. Kivipelto,et al.  Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence , 2006, Acta neurologica Scandinavica. Supplementum.

[22]  Albert Hofman,et al.  Serum lipids and hippocampal volume: The link to Alzheimer's disease? , 2005, Annals of neurology.

[23]  Patrick Browne,et al.  Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. , 2005, Archives of neurology.

[24]  C. Eckman,et al.  Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease* , 2004, Journal of Biological Chemistry.

[25]  B. Winblad,et al.  On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells , 2001, Neuroscience Letters.

[26]  E. Irle,et al.  Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals , 2009, Neurobiology of Aging.

[27]  S. Tabrizi,et al.  Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. , 2008, Brain : a journal of neurology.

[28]  A. Koudinov,et al.  Essential role for cholesterol in synaptic plasticity and neuronal degeneration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.